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1. Obstructive Sleep Apnea (OSA) 
 
1.1 Introduction 
  
 
Obstructive sleep apnea syndrome (OSAS) refers to a breathing disorder during sleep 
characterized by repeated episodes of upper airway obstruction resulting in cessation (apnea) 
or reduction (hypopnea) in airflow during sleep. OSAS results in recurrent hypoxic episodes 
during sleep, fragmented sleep, cardiovascular comorbidities, neurocognitive impairment 
during the day, and excessive daytime sleepiness.1-6 It is a frequent but insufficiently 
recognized disorder that involves at least 2% to 4% of subjects between 30 to 60 years old 
and up to 15% of the elderly population, with a 2:1 men/women ratio in Caucasians.7  
The scope of this work focuses on the role of OSA in associated cognitive impairment, the 
investigation of neural correlates of cognitive deficits and their evolution in response to 
treatment. 
 
1.2 OSA and cognitive function 
	  
It is now well recognized that OSAS is associated with cognitive impairment. Whereas there 
is no impact on general intelligence and verbal ability and there are inconsistent findings in 
respect to impact on memory, visual and motor skills8, a consistent negative impact of OSA 
is found in the literature in the realm of executive function and the ability to sustain attention 
for extended periods of time (vigilance) 8-10.   
“Executive function” is generally defined as a high-level cognitive function that allows us to 
organize our thoughts in a goal-directed way, plan and perform the sequence of necessary 
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actions while inhibiting irrelevant information and inappropriate behaviors. Executive 
abilities are believed to be supported essentially by the frontal lobes11. 
The domains of executive function that were most often impaired across studies of OSA 
patients are working memory, phonological fluency, cognitive flexibility and planning12, 13. 
In an attempt to link the physiological consequences of OSA to its behavioral and cognitive 
effects Beebe and Gozal have proposed a theoretical model, that attributes executive 
dysfunction to disruption of normal functioning of the prefrontal cortex (PFC), secondary to 
adverse cellular and biochemical events triggered by sleep disruption, intermittent hypoxia 
and hypercarbia in the context of OSA14. 
PFC has been established as the neurological correlate of executive function with different 
regions of PFC linked to different aspects of executive function, such as behavioral inhibition 
(orbital cortex) and working memory (DLPFC) and it is also the region primarily affected in 
aging subjects, schizophrenic patients and in healthy subjects after total sleep deprivation, all 
of whom manifest a certain degree of executive function impairment 15-22. The high 
sensitivity of this brain region to the effects of sleep deprivation was well demonstrated by 
several studies done on healthy volunteers 20, 23. However, even if the PFC is recognized as 
the primary brain region supporting executive function, neuroimaging studies have revealed 
that an efficient interplay of activation and deactivation of a network of regions is necessary 
for optimal behavioral performance (see below). Therefore, executive dysfunction can arise 
not only from lesions to the PFC, but also other regions of this network, or even from a less 
efficient functional connectivity within it. 
 
 1.2.1 Working memory and n-back task 
 
Working memory (WM) represents an aspect of “executive function” and is defined as an 
online information processing system that enables the maintenance and manipulation of 
information in the service of higher-order tasks, such as reasoning, planning and problem-
solving24. 
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WM is commonly the most studied aspect of executive function in neuroimaging and 
behavioral literature, often using the n-back task that requires subjects to compare the current 
stimulus with the one presented n-stimuli back.  
The n-back paradigm requires a continuous monitoring of sequentially presented stimuli, and 
subjects must answer whether the current stimulus matches the stimulus occurring n positions 
back in the sequence. The task combines maintenance as well as active manipulation, i.e., 
executive processes, because of the necessity to continuously encode, update, and discard the 
information held in WM with the presentation of each new stimulus. The value of n is 
regarded as proportional to memory load25. 
Load manipulation yields information in respect to the cognitive capacity and limit thereof in 
the studied population. This is particularly important in situations where cognitive deficit is 
mild and could be masked by a ceiling effect of an easy cognitive task. It is worth mentioning 
that most studies in OSA patients that used an n-back task, have used 2-back as their 
maximal task load, which possibly did not allow to examine the limit-of-capacity domain of 
WM in these patients.  
 
 
1.3 Continuous Positive Airway Pressure (CPAP) 
 
Historically, the first treatments of OSA were surgical, consisting in the beginning of 
tracheostomy, uvulopalatopharyngoplasty (UPPP), followed in later years by maxillo-
mandibular advancement. In 1981 Collin Sullivan proposed a new non-surgical treatment of 
OSA, which quickly became the gold standard treatment option for the majority of OSA 
patients. 
Positive air-pressure of nasal CPAP, acting as a pneumatic splint for the nasopharangeal 
airway allows normalization of sleep by preventing airway collapse secondary to sleep-
induced decrease of muscle tonus of pharyngeal walls and base of the tongue. 
It is well established that CPAP treatment significantly improves daytime sleepiness, quality 
of life and several aspects of cognitive function in OSA patients. However, it now appears 
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that even the most optimally treated and compliant patients with OSA may not experience a 
complete reversal of daytime symptoms and functional abnormalities26. Moreover, some 
aspects of cognitive impairment, such as executive function, seem to be less reversible than 
others. This observation led to the hypothesis that OSA patients sustain permanent cellular 
damage, possibly due to repetitive hypoxic injury, which is supported by recent results of 
volumetric studies. 
Most studies assessing the efficacy of CPAP on cognition have been conducted using 
behavioral measures as their outcome. However, little could be inferred about the 
neurological substrate of the observed deficits until behavioral performance was coupled 
with neuroimagery. 
 
2. Neuroimagery 
 
A number of neuroimaging studies have been conducted in OSA patients in order to uncover 
the particularities of brain metabolism (Positron Emission Tomography studies) and brain 
structure (spectroscopy, Voxel Based Morphometry studies)27. 
In the current work we are going to focus on Functional Magnetic Resonance Imaging 
(fMRI) studies that allow the investigation of neural correlates of the behavioral performance 
during a given cognitive task with a high spatial and temporal resolution. 
 
2.2 Functional Magnetic Resonance Imaging (fMRI) 
	  
BOLD (Blood Oxygenation Level Dependent) fMRI is a relatively new imaging technique 
that enables non-invasive investigation of brain function by detecting changes in the 
magnetic susceptibility of blood28.  
Neural processes related to a given cognitive task require an increase in neuronal metabolism 
with increased demand for energy consumption. Vascular response to this demand in the 
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brain has the particularity of a disproportional increase of local cerebral blood flow in respect 
to the metabolic demand, leading to a local shift in the relationship of oxygenated to 
deoxygenated hemoglobin  towards an increase of oxygenated hemoglobin. BOLD fMRI is 
based on the detection of changes in magnetic signal related to changes in deoxyhemoglobin 
concentration in the small vessels supplying the brain region involved in a given cognitive 
task. Therefore, whereas BOLD fMRI represents a non-invasive and safe technique for 
investigation of neuronal processes, it is important to account for the fact that it does so 
indirectly, by looking at vascular changes related to neuronal changes, and is thus susceptible 
to conditions that can introduce vascular confounds. 
fMRI studies of WM in healthy volunteers have established a network of brain regions 
activated during WM tasks, consistent mostly of fronto-parietal regions and referred to as 
Task Positive Network (TPN).   More recently, research has started to focus on a network of 
regions that exhibits a progressive deactivation during performance of cognitive tasks, the 
Task-Induced Deactivation Network. The Task-Induced Deactivation Network has been 
shown to consist of the same brain regions as the functionally connected resting state Default 
Mode Network (DMN), which is anti-correlated with the TPN and plays a crucial role for 
optimal behavioral performance. Since Task-Induced Deactivation Network and the DMN 
consist of the same brain regions and represent the same functional entity, in this work we 
shall refer to task-induced deactivation regions as the DMN. 
To date, 3 neuroimaging studies have examined aspects of executive function in OSA 
patients, with varying results. Patterns of reduced or increased brain activation have been 
reported in association with decreased or comparable behavioral performance relative to that 
of healthy controls.29-32 However, most of the interest has been directed at the network of 
brain regions known to be consistently activated during sustained attention and performance 
of cognitive tasks and referred to as the task positive network (TPN), which comprise a set of 
frontal and parietal cortical regions.33, 34 
In particular, the dorsolateral prefrontal cortex (DLPFC) is known to be a key region for 
performance of executive function tasks but is also the region primarily affected in aging 
subjects, schizophrenic patients, and in healthy subjects after total sleep deprivation, all of 
whom manifest a certain degree of executive function impairment.15-22 The high sensitivity of 
8	  
	  
this brain region to the effects of sleep deprivation was well demonstrated by several studies 
done on healthy volunteers,20, 23 making the DLPFC a region of special interest in cognition-
related research in OSA patients.  
However, there is increasing evidence that examination of activation in TPN alone does not 
yield a comprehensive view of cerebral response to cognitive demand. Contrary to TPN, it 
has been demonstrated that a set of brain regions referred to as the default mode network 
(DMN), comprising medial prefrontal, posterior cingulate, anterior temporal and lateral 
parietal cortices, exhibits tonic activation at rest and responds with progressive deactivation 
as the brain engages into a goal-directed activity.35, 36 There is growing evidence that DMN 
plays a key role in enabling optimal cognitive functioning and that DMN dysfunction, as well 
as DMN versus TPN anti-correlation imbalance, are associated with cognitive performance 
impairment.37 Several studies demonstrate that both networks and their reciprocal 
relationship contribute to the behavioral deficits observed in several pathological conditions 
as well as normal aging. 
In OSAS patients, repetitive hypoxia and repetitive disruption of sleep associated with sleep 
disordered breathing have been considered as potential factors in induction of cognitive 
deficit; however, given their simultaneous occurrence, teasing apart the degree to which each 
of those factors influences cognition as well as what aspects of cognition  are preferentially 
influenced by which OSAS factor is a challenge. Obesity is known to be associated with 
OSA, and the complex syndrome involving both abdominal obesity and OSA may lead to the 
metabolic syndrome (MetS), which comprises insulin resistance, central obesity, HTN, 
glucose intolerance, and dyslipidemia.38, 39 Several components of MetS are also associated 
with cognitive dysfunction. In particular, there is increasing evidence that obesity as 
expressed by the body mass index (BMI) is associated with cognitive impairment and is a 
risk factor for developing dementia.40-42 Since sleep fragmentation, intermittent hypoxia, and 
obesity are all factors commonly associated with OSA, it is likely that each of those factors 
has an impact on cognitive function of OSA patients and that their association may have a 
synergistic effect.  
Therefore in an attempt to provide a more comprehensive view of neuronal activation 
changes in OSA patients in our study we are investigating changes in both WM-activation 
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related (TPN) and deactivation related (DMN) networks and examine the independent 
contributions of sleep fragmentation (SF), intermittent hypoxia (IH), and BMI on brain 
activation of untreated patients with OSAS during the performance of a parametric working 
memory (WM) task in respect to both TPN and DMN. 
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Part 1 
 
Task Positive and Default Mode Networks during a Parametric Working 
Memory Task in Obstructive Sleep Apnea Patients and Healthy Controls 
 
The aims of the first part of this study were: (a) to examine the behavioral performance and 
the underlying brain activation and deactivation patterns in TPN- and DMN-related regions 
of a sample of untreated OSA patients on a parametric WM n-back task including a limit-of-
capacity 3-back level with functional magnetic resonance imaging (fMRI); (b) to compare 
these patterns  to findings in a matched group of healthy controls (HC); and (c) to examine 
the possible correlations between SF, IH, and BMI and brain activation in TPN and DMN. 
Based on results of previous literature, we hypothesized that: 
a) OSA patients will have larger areas of activation in the TPN than HC (spatial 
recruitment) in order to compensate for a possibly impaired function of the TPN, 
which would be manifested by higher BOLD signal in HC than in OSA patients in the 
TPN regions. 
b) OSA patients will have larger areas of deactivation in the DMN (compensatory 
spatial recruitment) as compared to HC in order to compensate for possibly 
ineffective deactivation of DMN, which would be manifested by higher BOLD signal 
in OSA patients than in HC in the DMN regions.  
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Methods 
Subjects 
Seventeen men diagnosed with moderate to severe OSAS were recruited from the Stanford 
Sleep Clinic and surrounding area via advertisement. All participants were right-handed 
nonsmokers and were screened for current or previous neurological and psychiatric disorder 
as determined by history, clinical evaluation, and Hamilton Depression Scale score. All 
participants reported regular sleep schedules with ≥6 h of sleep per night as determined by 
sleep habits questionnaires. Seven age-matched subjects without history of sleep disorders 
were recruited from the community as HC; and  absence of sleep pathology, including sleep 
disordered breathing (SDB), was confirmed by an overnight polysomnography (PSG: AHI 
<5) (Table 1). 
The study was approved by the Stanford Institutional Review Board, and all subjects signed 
informed consent. 
 
Polysomnography (PSG) 
Overnight PSGs were performed in all subjects. The following variables were systematically 
monitored: EEG, electro-oculogram, electrocardiogram, chin and leg myogram, nasal air 
flow with nasal cannula, abdominal and thoracic respiratory movements with piezo-electrical 
belts, and pulse oximetry. Studies were scored by independent technicians and reviewed by a 
qualified sleep medicine physician according to the AASM scoring criteria.  
 
Experimental Procedure and n-Back Task 
All subjects were instructed to abstain from ingestion of any caffeinated beverages ≥9 h prior 
to scanning.     
During the fMRI session, participants performed 2 sessions of visuospatial n-back task that 
was generated with E-Prime 1.0 software and visually projected on a mirror in front of the 
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subject’s eyes. They performed two 9 min 40 sec sessions of a block-designed parametric n-
back task with 4 levels of difficulty (0-back, 1-back, 2-back, and 3-back). Each session 
comprised 2 blocks of each WM condition (1-, 2-, and 3-back) of 63 sec duration, separated 
by 5 blocks of the baseline condition (0-back) of 25.2 sec duration each (0-1-0-2-0-3-0-1-0-
2-0-3). During the task, a white dot flashed for 200 ms in 6 pseudo-random locations on a 
black screen. Fifty percent of stimuli were matches. 
Subjects were instructed to respond with their right hand (index finger for matches and 
middle finger for mismatch) whether the dot appeared on the left or on the right side of the 
screen in the 0-back condition, or whether each given dot appeared in the same or different 
location as the dot n-dots before for the 1-, 2-, and 3-back conditions, respectively. Subjects’ 
responses during the n-back sessions and their response times (RT) in the scan were recorded 
via a custom-made response box in E-Prime Data Aid software. 
 
fMRI Data Acquisition 
Functional MRI data was acquired on a 3.0T GE (Milwaukee, WI) whole-body scanner with 
a custom quadrature bird-cage head coil. Head movement was minimized with foam padding. 
Thirty oblique axial slices were taken parallel to the anterior/ posterior commissure plane 
(AC-PC) with 4-mm slice thickness, 1-mm interslice gap. High resolution T2 weighted fast 
spin echo structural images were acquired for anatomical reference. A T2*-sensitive gradient 
echo spiral in/out pulse sequence43 was used for functional imaging (TR = 2000 ms, TE = 30 
msec, flip angle = 70, FOV = 24 cm, matrix = 64 x 64). An automated high-order shimming 
procedure based on spiral acquisitions was used to reduce B0 heterogeneity.44 A high 
resolution T1 volume scan (124 slices, 1.2-mm thickness) was collected for every subject 
using an IR-prep FSPGR sequence for T1 contrast. 
 
fMRI Data Analysis 
Functional MRI data were preprocessed and analyzed using Statistical Parametric Mapping 
software (Welcome Department of Cognitive Neurology, London) and custom MATLAB 
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routines (MathWorks Natick, MA). The preprocessing steps consisted of realignment of all 
images to the first image, normalization to MNI template, and spatial smoothing with a 
Gaussian filter of 6 mm full-width-half-maximum.  
To test for the effect of each task load, we used a standard general linear approach with 4 
regressors for the 3 task load and baseline conditions, modeled as a boxcar function 
convolved with the canonical HRF. The 6 motion parameters from the realignment were 
added as 6 regressors of no interest. Statistical analysis at the single-subject level treated each 
voxel according to a general linear model.45 Individual contrast images were created by 
computing each WM task load versus the 0-back load baseline (1 > 0, 2 > 0, 3 > 0). OSA and 
HC groups were then compared for each WM task load by entering individual contrast 
images in a 2-sample t-test. For each of the 3 main contrasts, we also used an ANOVA and 
performed an exclusive masking procedure to reveal any voxel significantly activated in one 
group but not in the other group (Fig. 1). 
In order to minimize the type I error, a cluster threshold method was used,46 requiring that 
any given voxel  be significantly activated at P  level of 0.001 and be a part of a cluster of 
≥10 contiguous significantly activated voxels. 
To test for correlation of a general task load effect with clinical measures, we performed a 
second analysis on the patient dataset using a multiple regression approach. We first designed 
a parametric model where all task blocks were modelled as one single regressor, with 2 
additional regressors modeling a linear modulation of the task-related activity by load level 
(1-, 2-, and 3-back), a quadratic modulation of the task-related activity by load level, and 7 
regressors of no interest (behavioral performance per task block and 6 motion correction 
parameters). Contrast images generated by the linear load regressor from each subject 
entered the multiple regression group analysis with AHI, time spent under 90% SpO2 
(minutes), and BMI as covariates. These analyses were performed on the data from the OSA 
patients only. 
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Results 
Clinical Measure and Behavioral Performance 
For 17 OSA patients, the mean AHI was 39.7 (±22.8), the mean Epworth score was 7.3 (±4), 
and the mean BMI was 27.8 (±4) kg/m2. Mean minimal nocturnal oxygen saturation was 
87.8% (±8.9%). Details of sleep quality and sleep stages are reported in Table 1. 
During scanning subjects’ accuracy decreased and response time increased with increasing n-
back load. There was no difference in RT between OSA patients and HC on any level of the 
task load. OSA patients performed significantly worse than HC on the 3-back (79% versus 
89% correct, P = 0.005), but there was no significant difference in performance for the other 
levels of task load (Table 2). Significant negative correlation between BMI and behavioral 
performance was found at the 3-back level (r = −0.7). 
In order to exclude an influence of sleepiness on brain activation and performance, we 
examined a possible relationship between RT during the 0-back epochs throughout both 
sessions of the n-back task with task duration. There was no correlation between RT and task 
duration for either session. 
 
fMRI 
Working Memory Load 
Comparing activity during each WM load versus baseline revealed 2 distinct networks. 
Significant activations were found in several brain regions previously described to be 
involved in WM processing in other fMRI studies using n-back tasks. Those included 
bilateral SMA, bilateral DLPFC, anterior cingulate cortex (ACC), and parietal cortex 
bilaterally.   
On the other hand, significant deactivations with increasing load were found in the medial 
PFC, posterior cingulate cortex, bilateral insular and hippocampal cortex (DMN).  
Both activation and deactivation networks showed a progressively marked pattern with 
increasing task load (Fig. 3). 
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Comparison between OSA Patients and Healthy Controls 
For the 1-back versus baseline comparison, significantly higher  activation was found in HC 
than in OSA patients in bilateral parahippocampal regions, right insula, bilateral claustrum, 
left precentral gyrus (BA 4), and right precuneus (BA 7) (Fig. 2A, Table 3). Significantly 
higher activation was found in the left temporo-occipital area (BA19) in OSA patients than in 
HC. 
For the 2-back versus baseline comparison, HC had higher activation than OSA patients in 
right precentral (BA 44) and left middle frontal gyrus (BA 10), whereas OSA patients had 
higher activation in bilateral temporal (BA 37) and left occipital (BA 17) regions (Fig. 2B, 
Table 2). 
In the 3-back versus baseline comparison, HC had higher activation than OSA patients in 
right precentral gyrus (BA 44), whereas OSA patients had higher activations in the left 
middle frontal (BA 8) region (Fig. 2C, Table 2). 
Using exclusive masking of WM activated regions in OSA patients by activation in HC, we 
found a higher number of activated regions in OSA group at both 2- and 3- versus 0-back 
loads, with maximal effect at the highest difficulty level (3- vs 0-back) in TPN-related 
regions (Fig. 3A). DMN pattern showed a different pattern with higher number of 
deactivated regions in OSA patients as compared to HC in the 1 and 2- vs 0-back comparison 
and a recruitment of a different set of deactivated regions in HC at the 3- vs 0-back 
comparison, consisting of bilateral occipital (cuneus) and temporal regions (BA 21) (Fig. 3B) 
At the 3-back level, OSA patients still showed more widespread DMN recruitment in the 
bilateral insulas, anterior and posterior midline and posterior parahippocampal regions as 
compared to HC. 
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Multiple Regression Analysis 
Multiple regression analysis yielded significant positive correlation between AHI and brain 
activation across WM task loads in the left and right frontal regions (L BA 6, 10, R BA 10) 
(Fig. 2A, Table 4).  
We found a positive correlation between brain activation across WM task loads and sleep 
time spent under 90% SpO2 in bilateral inferior frontal lobe regions (BA 47), right medial 
frontal gyrus (BA 11), right anterior and bilateral posterior cingulate (R BA 24, L BA 23, 
29), left subcallosal gyrus (BA 25), left precentral region (BA 6), bilateral temporal poles 
(BA 38), right parahippocampal gyrus (BA 34), bilateral occipital regions (L BA 18, R BA 
31), and left cerebellar regions (culmen). Negative correlation was found in the bilateral 
frontal (L BA 6, R BA 8) and left parietal lobes (BA 2, 7) (Fig. 2B, Table 4). 
Significant negative correlations have been found for BMI in left frontal cortex (BA 10), 
right temporal (BA 42), left claustrum, bilateral occipital (BA 18, 19), and cerebellar regions. 
There was no positive correlation between BMI and brain activation across the WM task 
loads. 
 
Discussion 
Recent research on task positive and default mode networks in the human brain indicates that 
dysfunction of both those networks, as well as the imbalance of the antagonistic relationship 
between them, can lead to behavioral impairment and are in fact observed in several 
conditions associated with cognitive deficit, such as normal aging, Alzheimer disease, 
schizophrenia, ADHD, and depression.47 In particular, it has been shown that the extent of 
task-related deactivations in the DMN could differentiate between subjects with mild 
cognitive impairment, Alzheimer disease, and healthy controls, with lesser deactivation in 
MCI than healthy controls and in Alzheimer patients than in MCI.48 Furthermore, Lawrence 
et al have demonstrated that good behavioral performance on a sustained attention/WM task 
can arise from stronger activation in the TPN, stronger deactivation in the DMN, or a mixture 
of strong levels of activation and deactivation.49 
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In our study, both groups demonstrated a progressive increase of spatial recruitment of 
regions within and adjacent to the TPN from 1- to 3-back level of task, probably reflecting a 
continuous compensatory effort, with a larger recruitment in OSA subjects as compared to 
HC. However, the groups differed in the task-related deactivation of the DMN with more 
widespread deactivation (DMN spatial recruitment) in OSA than in HC at the 1 and 2-back 
level and a different pattern of compensatory recruitment in the two groups at the 3-back 
level, in spite of a continuous spatial recruitment of DMN regions in both groups with 
increasing load (Fig. 3). 
Therefore, significantly worse behavioral performance of OSA patients at the 3-back level 
appears to be related more to a different pattern of recruitment and deactivation of DMN-
related regions than a defective TPN. 
Our finding of positive correlation between cerebral activation during the n-back task and the 
measure of nocturnal desaturation in a number of regions of and adjacent to the DMN 
(particularly in bilateral temporal poles and mesial temporal regions) suggests intermittent 
hypoxia to be a major factor for the DMN dysfunction in OSA patients. IH was also found to 
have a negative impact on TPN regions, with a negative correlation between IH and cerebral 
activation in bilateral frontal and left parietal regions. 
Defective deactivation of a network of brain regions commonly more active during rest than 
during a cognitive task (DMN) has been demonstrated to be related to worse behavioral 
performance in a number of conditions associated with cognitive impairment and sleep 
disturbances (normal aging, Parkinson disease, schizophrenia, ADHD), suggesting that 
inability to reallocate neuronal resources and suppress activity in neighboring regions plays a 
role in cognitive impairment.50-53 Disruption of task-related deactivation within the midline 
regions of DMN has been reported after acute sleep deprivation,54 and slower reaction times 
on a psychomotor vigilance task have also been associated with increased activation in 
midline DMN regions after total sleep deprivation,55 suggesting that sleep deprivation has a 
direct impact on DMN. Similarly, reduced deactivation in the posterior regions of DMN has 
been shown to be related to attentional lapses in healthy subjects.56 In regard to those 
findings, the observed recrutement in midlineregions of DMN in OSA patients in our study 
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together withthe absence of changes in reaction times suggests that sleep deprivation is not 
the mechanism that dysregulates DMN in OSA patients. 
We found significantly increased brain activation in HC as compared to OSA patients in 
several regions of the limbic system at the 1- versus 0-back comparison. The analysis of 
parameter estimates trend revealed a peak of BOLD signal at 1-back in HC that is absent in 
OSA patients. Several of those brain regions are known to be implicated in emotional and 
autonomic nervous system control.57-60 It is well established that OSAS is associated with 
autonomic nervous system dysfunction.61, 62 Therefore, we believe that the observed 
difference in activation reflects a blunted autonomic response in OSA patients. Indeed, the 
design of our task means that each session began with the 1-back task as the first load block 
(see Methods), clearly enhancing the risk of task-related stress due to the new situation 
during this test. This proposition is further supported by a re-analysis of data that considered 
only the second part of each session, in which there was no difference between patients and 
HC in those regions. Further studies including autonomic nervous system measures are 
needed in order to evaluate more in depth this specific aspect of the testing situation. 
Finally, more and more attention is being directed to the effect of obesity per se on cognitive 
function, as it has been shown that excess body weight is associated with brain structural and 
functional alterations63 and a higher risk of developing dementia in later life.40 Higher BMI 
was found to be associated with hypometabolism as well as reduced NAA/Cho ratio of the 
prefrontal and cingulated regions.64, 65 Behaviorally, several studies find a significant 
relationship between high BMI and cognitive dysfunction in otherwise healthy adults or after 
controlling for BP, age, and diabetes.40, 41, 66 Since obesity is strongly associated with OSA 
due to patient recruitment, it is important to examine the independent effect of BMI on 
cognitive function of OSA patients and to systematically account for its effect in cognition 
studies in these subjects. Our results are in line with previous literature, as we found only 
negative correlations between BMI and brain activation during the WM task in a number of 
brain regions of the TPN, in particular in bilateral DLPFC and occipital and cerebellar 
regions. Not surprisingly, BMI and desaturation time were significantly correlated in our 
sample, hence using a multiple regression model allowed us to tease apart their independent 
influence on cerebral activation during the WM task. However, despite the significant 
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correlation between BMI and desaturation time, only BMI was significantly negatively 
correlated with behavioral performance at the limit-of-capacity level of task (3-back), 
suggesting that BMI has a more deleterious role on WM function in OSA than sleep 
fragmentation and nocturnal desaturation. This finding and the fact that only negative 
correlations were found between BMI and cerebral activation suggests that BMI has a 
structural impact on the grey matter of the TPN. Thus, further studies are needed to 
investigate the independent impact of BMI and the effect of obesity treatment on cognitive 
function in OSA. 
Several neuroimaging studies have previously investigated executive function aspects in 
OSA patients. Thomas et al reported a decreased brain activation in anterior cingulate, 
bilateral DLPFC, and posterior parietal regions in OSA patients during the performance of a 
2-back verbal task, which paralleled a significantly worse behavioral performance as 
compared to healthy controls.29 Ayalon et al, using a Go-no-Go task, reported a decreased 
cerebral activation in several regions typically involved in attentional tasks in patients 
compared to controls, whereas there was no significant difference in behavioral performance 
and response time between the two groups for the Go versus rest (although there was a trend 
towards worse performance in patients for the No-go versus rest comparison).30, 31 
Castronovo et al have reported an increased activation in OSA patients versus HC in left 
frontal regions, precuneus, putamen, hippocampus, and cerebellum, as well as decreased 
activation in brainstem, left occipital, and right orbital regions at similar behavioral 
performance at a 2-back task.32 
Our study differs from previous studies on several points: (a) it considers a visuospatial (and 
not a verbal) n-back task, (b) it involves 4 levels of difficulty, and (c) it examines BOLD 
signal changes in not only the TPN but also the DMN regions. It is therefore more difficult to 
draw direct comparisons between our results and results of previous studies. However, 
similar to previous studies we found an increase in spatial recruitment of TPN, in particular 
of the left hemisphere, in OSA patients as compared to HC, as well as a decrease in 
activation in frontal regions involved in WM function, particularly at more difficult task 
levels. Moreover, Castronovo et al have reported an increased activation in the precuneus in 
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their OSA group, which partly corroborates our results of decreased deactivation in posterior 
regions of DMN.   
Our study has limitations: we have examined only male subjects, as controversy exists about 
gender effects on brain activation during cognitive performance; therefore our results cannot 
be extended to female OSA patients. Our patient and HC groups also significantly differed in 
the average of years of schooling, introducing the question of contribution of intelligence 
level (when based on years of schooling) to the observed behavioral and neuronal 
differences. We believe however that this bias is not as important as it seems: although 
statistically significant, the schooling difference between the groups was small, and both 
groups had a high educational level (mean of 16.5 and 18.9 years). Having a more reliable 
measure of fluid intelligence than the education level would be certainly more relevant.  
Whereas the design of our task demanded an alternation between four task levels—the 1-, 2-, 
and 3-back blocks having a duration of 1 min for a total of 4 min on each task level per 
patient not allowing observation of potential effects due to a long time-on-task—it enabled us 
to include a limit-of-capacity 3-back level in our parametric design, requesting more effort 
from patients and HC. As our primary interest was the difference in WM function, shorter 
block duration gave us the advantage of not having the confounding effect of fatigue, 
typically seen in sleep deprived subject in designs with long time-on-task blocks. But the 
fixed order of increasing load difficulty in our task design, while likely enabling us to 
uncover a different trend of response to stress between the two groups, may have masked 
more WM-related effects at the low-load level. We believe that differences in task designs 
between various studies, although making the result comparison more difficult, yield 
complementary information on brain function in OSAS. 
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Table 1: Sample characteristics 
 
    
Age 43.2 (±8.4) 
BMI 27.8 (±4) 
AHI 39.7 (±22.8) 
Ethnicity 
4 Asian, 12 Caucasian, 1 
Hispanic 
TST 376.8 (±71.1) 
Sleep 
efficiency 83.1 (±13.1) 
REM 17.9 (±4.9) 
Stage 1 12 (±7.3) 
Stage 3+4 7.9 (±8.9) 
Min SpO2 87.8 (±8.9) 
    
 
BMI = body mass index, AHI = apnea hypopnea index, TST = total sleep time 
Table 2: Behavioral performance in OSA patients and HC 
 
        
  OSA patients HC 
P 
value 
    
Accuracy 0-back 99 (±2.5) 99.5 (±0.8) 0.5 
RT 0-back 466.9 (±125.6) 446.2 (±117.5) 0.7 
Accuracy 1-back 96.7 (±4.7) 96.3 (±4.3) 0.9 
RT 1-back 762.7 (±167) 671.3 (±182.8) 0.3 
Accuracy 2-back 91.4 (±6.8) 93.6 (±5.3) 0.4 
RT 2-back 984.6 (±318.2) 806.8 (±274.2) 0.19 
Accuracy 3-back 78.9 (±10.6) 89 (±5.2) 0.005 
RT 3-back 1197.1 (±322)  992.1 (±239.6) 0.1 
        
 
HC = healthy controls; RT = reaction time 
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Table 3: Talairach coordinates of brain regions showing significant differences in cerebral 
activation between OSA patients and healthy controls (t-test analysis) 
 
        
X  Y  Z  Brodman region  
    
OSA >HC 1- vs 
0-back     
    
-42 -59 18 L BA 19 
    
HC >OSA 1- vs 
0-back     
    
-30 -6 -11 L BA 34,38 
-40 2 -11  
-32 1 -9  
49 -19 -18 R BA 20 
20 -9 -18 R BA 34 
27 -20 -22 R BA 36 
18 -14 -24 R BA 28 
36 -8 8 R claustrum 
45 -7 1 R insula 
-45 -18 -22 L BA 20 
-17 -16 -23 L BA 28 
-51 -11 26 L BA 4 
-12 -88 -13 L BA 18 
38 4 -4 R claustrum 
2 -44 47 R BA 7 
    
OSA >HC 2- vs 
0-back     
    
6 -33 17 R pulvinar 
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51 -50 -9 R BA 37 
-44 -49 -8 L BA 37 
-12 -95 -3 L BA 17 
    
HC >OSA 2- vs 
0-back     
    
-38 39 9 L BA 10 
51 3 13 R BA 44 
    
OSA >HC 3- vs 
0-back     
    
-27 -76 -5 L BA 19 
-35 18 38 L BA 8 
    
HC >OSA 3- vs 
0-back     
    
56 7 11 R BA 44 
    
 
(P = 0.001, voxel extent threshold = 10) 
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Table 4: Talairach coordinates of brain regions showing significant correlation with AHI, 
desaturation time, BMI, and cerebral activation during the WM task 
 
        
X  Y  Z  Brodman region 
    
Positive correlations with AHI   
    
-32 37 9 L BA 10 
-57 -2 27 L BA 6 
38 43 7 R BA 10 
    
Negative correlations with AHI   
    
-16 -30 -19 culmen 
    
Positive correlations with Desaturation Time 
    
-49 29 -3 L BA 47 
24 34 29 R BA 47 
5 28 -15 R BA 11 
-1 17 -12 L BA 25 
5 31 -5 R BA 24 
-9 -13 24 L BA 23 
6 -69 21 R BA 31 
-16 -48 14 L BA 29 
-43 17 -16 L BA 38 
38 19 -13 R BA 38 
-9 -73 21 L BA 18 
29 2 -17 R BA 34 
-14 -31 -21 culmen 
    
Negative correlations with Desaturation Time 
    
45 11 42 R BA 8 
-57 -2 30 L BA 6 
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-29 -50 39 L BA 7 
-48 -16 48 L BA 2 
    
Negative correlations with BMI   
    
-29 50 12 L BA 10 
60 -13 14 R BA 42 
-11 -73 21 L BA 18 
-23 -50 -3 L BA 19 
19 -52 0 R BA 19 
-34 -12 -5 L claustrum 
29 2 -18 R BA 34 
-23 -34 -28 L cerebellum 
-19 -39 -23 L cerebellum 
20 -33 -26 R cerebellum 
23 -38 -30 R cerebellum 
        
 
 (P = 0.001, voxel extent threshold = 10) 
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Figure 1: Spatial recruitment of A: TPN in OSA patients after exclusive masking by brain 
activation of the HC group (left) and spatial recruitment of TPN in HC after exclusive 
masking by brain activation of OSA group (right); B: DMN in OSA patients after exclusive 
masking by brain deactivation of the HC group (left) and spatial recruitment of DMN in HC 
after exclusive masking by brain deactivation of OSA group (right). Exclusive masking 
(p=0.05), FDR correction for multiple comparisons (p=0.05).      
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Fig. 2: Brain regions significantly higher activated in HC compared to OSA patients in cold 
scheme; brain regions significantly higher activated in OSA patients as compared to HC in 
warm color scheme. A: 1- versus 0-back comparison, B: 2- versus 0-back comparison, C: 3- 
versus 0-back comparison. Correlations between cerebral activation during WM task in OSA 
patients and D: AHI, E: nocturnal desaturation time (min), F: BMI. Images presented in 
radiologic convention. 
 
 
 
 
 
 
 
 
 
29	  
	  
Fig. 3: Cerebral activation (warm color scheme) and deactivation (cold color scheme) in A: 
OSA patients and B: healthy controls for 1-, 2-, and 3 versus 0-back contrasts. 
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Part 2 
 
The Effects of CPAP treatment on Task Positive and Default Mode 
Networks in Obstructive Sleep Apnea Patients: an fMRI Study 
 
 
The aim of the second part of this study was to investigate both cerebral activation and 
deactivation patterns in response to a visuo-spatial parametric working memory (WM) task 
(executive function) in patients with moderate to severe OSA before and after CPAP 
treatment in a randomized, sub-therapeutic CPAP (sham)-group controlled fashion, and to 
compare it to the response of healthy controls.   
 
Methods 
 
Subjects 
Seventeen men diagnosed with moderate to severe OSAS were recruited from the Stanford 
Sleep Clinic and surrounding area via advertisement. All participants were right-handed 
nonsmokers and were screened for current or previous neurological and psychiatric disorder 
as determined by history, clinical evaluation, and Hamilton Depression Scale score. All 
participants reported regular sleep schedules with ≥6 h of sleep per night as determined by 
sleep habits questionnaires. Seven age-matched subjects without history of sleep disorders 
were recruited from the community as HC; and  absence of sleep pathology, including sleep 
disordered breathing (SDB), was confirmed by an overnight polysomnography (PSG: AHI 
<5). 
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Patients who were confirmed to have OSA on diagnostic PSG were randomly assigned to 
either the active (therapeutic) or sham (sub-therapeutic) nasal CPAP group. A CPAP titration 
study was conducted for patients in both groups, during which active group subjects were 
effectively titrated and sham group subjects slept with the sub-therapeutic nasal CPAP. The 
sham-CPAP device closely simulated the airflow through the exhalation port and the 
operating noise of the active-CPAP device. Prior study using a functionally similar sham-
CPAP device revealed that oxygen saturation, end-tidal CO2, and mean temperature and 
humidity measured at the CPAP mask were the same 
with active versus sham-CPAP67. No significant difference was found in sleep parameters or 
the number of abnormal respiratory events between the sham-CPAP group and a no-
treatment group in 10 men with OSA. Subjects in both groups were treated for 2 months and 
treatment compliance was monitored using Encore® Pro Smart Card® system. At the end of 
the treatment period, sham-CPAP group subjects underwent a second CPAP titration night 
and left the study with therapeutic CPAP treatment. 
 
The study was approved by the Stanford Institutional Review Board, and all subjects signed 
informed consent. 
 
Polysomnography (PSG) 
See Methods Part 1 
 
Experimental Proedure and n-Back Task 
See Methods Part 1 
. 
fMRI Data Acquisition 
See Methods Part 1 
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fMRI Data Analysis 
Functional MRI data were preprocessed and analyzed using Statistical Parametric Mapping 
software (Welcome Department of Cognitive Neurology, London) and custom MATLAB 
routines (MathWorks Natick, MA). The preprocessing steps consisted of realignment of all 
images to the first image, normalization to MNI template, and spatial smoothing with a 
Gaussian filter of 6 mm full-width-half-maximum.  
To test for the effect of each task load, we used a standard general linear approach with 4 
regressors for the 3 task load and baseline conditions, modeled as a boxcar function 
convolved with the canonical HRF. The 6 motion parameters from the realignment were 
added as 6 regressors of no interest. Statistical analysis at the single-subject level treated each 
voxel according to a general linear model.45 Individual contrast images were created by 
computing each WM task load versus the 0-back load baseline (1 > 0, 2 > 0, 3 > 0). For 
group analysis, for each of the 3 main contrasts a one-sample T-test was used for each group 
and an exclusive masking procedure was performed on baseline and post-treatment sessions 
to reveal any voxel significantly activated in one but not in the other session.  
We also designed a parametric model where all task blocks were modeled as one single 
regressor, with 2 additional regressors modeling a linear modulation of the task-related 
activity by load level (1-, 2-, and 3-back), a quadratic modulation of the task-related activity 
by load level, and 6 regressors of no interest (behavioral performance per task block and 6 
motion correction parameters). 
Individual contrast images obtained from linear modulation of the parametric analysis were 
used in a paired t-test to compare baseline and post-treatment scans for sham and active 
CPAP groups. Full factorial analysis was used to examine the group x scan interaction.  
OSA and HC groups were compared for the 3 main contrasts (1 vs 0-back, 2 vs 0-back and 3 
vs 0-back) using an exclusive masking procedure to reveal voxels significantly activated in 
one but not in the other group. 
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In order to minimize the type I error, a cluster threshold method was used,46 requiring that 
any given voxel  be significantly activated at P  level of 0.001 and be a part of a cluster of 
≥10 contiguous significantly activated voxels. 
 
 
Results 
Clinical Measure and Behavioral Performance 
 
Baseline patient data 
For 17 OSA patients, the mean AHI was 39.7 (±22.8), the mean Epworth score was 7.3 (±4), 
and the mean BMI was 27.8 (±4) kg/m2. Mean minimal nocturnal oxygen saturation was 
87.8% (±8.9%). Details of sleep quality and sleep stages are reported in Table 5. There was 
no significant difference between sham and active-treatment groups in AHI, duration of 
nocturnal desaturation or performance. There was a significant difference in BMI (p=0.01) 
between the 2 patients’ groups (29.9+/-4.2 for active and 25.4+/-2.1 for sham).  
 
Behavioral performance at baseline and post-treatment 
During scanning subjects’ accuracy decreased and response time increased with increasing n-
back load. There was a significant group x session interaction between active and sham 
CPAP groups for RT on 3-back load (p=0.023). Active CPAP OSA patients’ group 
performed significantly worse than HC on the 3-back, both before (75.2% vs 89% correct, 
p=0.002) and after CPAP treatment, even if a trend for improvement after treatment was 
observed (78.7% versus 89% correct, P = 0.04). However, the significantly worse 
performance at 2-back before treatment got significantly better after CPAP treatment. There 
was no significant difference in performance for the other levels of task load (Table 6).  
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In order to exclude an influence of sleepiness on brain activation and performance, we 
examined a possible relationship between RT during the 0-back epochs throughout both 
sessions of the n-back task with task duration. There was no correlation between RT and task 
duration for either session. 
 
fMRI 
Categorical analysis 
The activation/deactivation patterns in our HC group mobilized cerebral regions previously 
described to be involved during performance of WM tasks.  In line with previous studies both 
activation and deactivation increased with increasing task difficulty in all groups. Activation 
was maximal at the 2-back level and deactivation at the 3-back level in the HC group, 
suggesting that TPN is more capacity constrained than DMN. In patient groups TPN 
activation was relatively comparable for 2 and 3-back, but inferior to that of HC at 2-back in 
a number of frontal and parietal regions, particularly DLPFC. We used the 
activation/deactivation pattern of our HC as our reference frame of comparison for TPN and 
DMN activity in our OSA patients. 
 
Sham-treatment group baseline scan exclusively masked with post-treatment scan 
Exclusive masking of activation of baseline scan by the post-treatment scan in sham-CPAP 
group revealed activation in left cuneus (BA 18), right inferior temporal gyrus (BA 37) and 
right inferior frontal gyrus (BA 47) for the 1>0 contrast; left hippocamal/parahippocampal 
region,  left fusiform gyrus (BA 37), and right middle temporal gyrus (BA 21) for the 2>0 
contrast; right frontal (BA 8,9,10), left frontal (BA 6,46), right inferior parietal lobule (BA 
40), right superior temporal gyrus (BA 39) and left insula (BA 13) for the 3>0 contrast 
(Table 7). 
 Deactivation was found in the right amygdale/uncus (BA 36) for the 1>0 contrast; bilateral 
superior temporal gyri (BA 38), left anterior and posterior cingulate gyrus (BA 25, 30), left 
inferior frontal gyrus (BA 47), left inferior temporal gyrus (BA 20) for the 2>0 contrast; 
36	  
	  
bilateral parietal (BA 5,7), bilateral amygdalas, right uncus (BA 34), right parahippocampal 
gyrus (BA 27, 30), medial frontal (BA 6,9), left medial frontal (BA 6),  left precentral (BA 
4), bilateral cerebellar regions, bilateral lingual gyri (BA 17, 18), right cuneus (BA 18),  right 
fusiform gyrus (BA 19), right cingulate (BA 25, 31), bilateral posterior cingulate (BA 29, 
30), right superior temporal (BA 38) for the 3>0 contrast (Fig. 4a). 
 
Sham-treatment group post -treatment scan exclusively masked with baseline scan 
Activation was found in bilateral superior frontal gyri (BA 6), right middle frontal gyrus (BA 
8), left superior frontal gyrus (BA 9,10), left precuneus (BA 7), bilateral cerebellar regions, 
periaqueductal grey and tectum in 1>0 contrast; left precentral, superior, and middle frontal 
gyri (BA 6,8,9), right precentral gyrus (BA 4), left middle temporal gyrus (BA 20), bilateral 
precuneus (R BA 31, L BA 7), left postcentral gyrus (BA 3) for 2>0 contrast; right medial 
frontal gyrus (BA 10) and right precuneus (BA 7) for 3>0 contrast. 
Deactivation was found in the left middle temporal gyrus (BA 19) for the 1>0 contrast; right 
medial frontal gyrus (BA 9) for 2>0 contrast; left inferior frontal gyrus (BA 45), bilateral 
insula (BA 13), right putamen, bilateral superior (BA 22) and right middle temporal gyri (BA 
21), right superior and middle temporal gyri (BA 39, 41), left postcentral and fusiform gyri 
(BA 20), right lingual gyrus (BA 17/19) and left superior occipital gyrus (BA 19) for 3>0 
contrast (Fig.4b). 
 
Active-treatment group baseline scan exclusively masked with post-treatment scan 
Activation was found in right inferior frontal gyrus (BA 45/46) for the 1>0 contrast; right 
cerebellum (tuber) for the 2>0 contrast; left precentral gyrus (BA 6) for the 3>0 contrast 
(Table 8). 
Deactivation was found in left middle temporal (BA 39), left medial frontal (BA 10), right 
inferior temporal gyrus (BA 20), right subcallosal (BA 34) and right parahippocampal gyri 
(BA 36) for the 1>0 contrast; right superior and medial frontal gyri (BA 8, 10), right insula 
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(BA 13), right putamen, right head of the caudate nucleus, right superior temporal gyrus (BA 
38), bilateral postcentral gyri (BA 3), left precentral gyrus (BA 6) for the 2>0 contrast; left 
superior parietal lobule and left cuneus (BA 7, 17), left paracentral lobule (BA 6), bilateral 
insula (BA 13), left medial frontal gyrus (BA 10),right medial frontal gyrus (BA 6), right 
precentral gyrus (BA 4), bilateral superior temporal gyri (BA 22), right precuneus (BA 31), 
right parahippocampal gyrus (BA 19), left fusiform gyrus (BA 19) and left culmen for 3>0 
contrast (Fig.5a). 
 
Active-treatment group post -treatment scan exclusively masked with baseline scan 
Activation was found in bilateral parietal lobules (BA 40), left middle frontal gyrus (BA 10), 
right superior frontal gyrus (BA 6), left precentral gyrus (BA 6) for the 1>0 contrast; bilateral 
medial and superior frontal gyri (BA 6), bilateral precuneus (BA 7), right superior temporal 
gyrus (BA 22), bilateral insula (BA 13), bilateral frontal regions (BA 6, L BA 4), right 
lingual gyrus (BA 18), right cuneus (BA 19), right cingulated gyrus (BA 24, 31), right 
precentral gyrus (BA 44), left superior, middle and inferior frontal gyri (BA 9), right middle 
occipital gyrus (BA 37), right inferior parietal gyrus (BA 40) for the 2>0 contast; left middle 
frontal gyrus (BA 9), right middle frontal gyrus (BA 6, 10), left middle frontal gyrus (BA 
46), bilateral cerebellum for 3>0 contrast. 
Deactivation was found in the right anterior cingulate gyrus (BA 24) and left inferior parietal 
lobule (BA 40) for the 1>0 contrast; bilateral insula (BA 13), right anterior cingulated gyrus 
(BA 24), right superior temporal gyrus (BA 41), left cuneus (BA 30), left postcentral gyrus 
(BA 43), left caudate nucleus, left superior frontal gyrus (BA 8) for the 2>0 contrast; bilateral 
superior temporal gyri (BA 22), right anterior cingulated (BA 25), right cingulate (BA 24, 
31), left medial globus pallidus, left putamen, right medial frontal gyrus (BA 11), right 
postcentral gyrus (BA 3, 5), right medial frontal gyrus (BA 10), left inferior frontal gyrus 
(BA 47), left middle temporal gyrus (BA 21), left cerebellum for 3>0 contrast (Fig.5b). 
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Parametrical analysis 
Paired T-test of baseline and post-treatment scan for the sham-treatment group revealed 
significantly higher activation in the right superior and middle frontal gyrus (BA 6, 8, 9), left 
superior and middle temporal gyri (BA 21, 22, 38), left inferior frontal gyrus (BA 47), 
bilateral putamen, head of the right caudate nucleus, left caudate nucleus body, left lateral 
globus pallidus,  left middle occipital gyrus (BA 18, 19), right precentral gyrus (BA 4, 6). No 
areas of significantly higher activation were found in the post-treatment as compared to the 
baseline scan (Fig.6a, Table 9). 
Paired T-test of baseline and post-treatment scan for the active-treatment group revealed 
significantly higher activation in the left superior temporal gyrus (BA 22), left middle 
occipital gyrus (BA 18) and right cuneus (BA 17). No areas of significantly higher activation 
were found in the post-treatment as compared to the baseline scan (Fig.6b). 
 
Discussion 
	  
This is the first study, to our knowledge, to specifically examine the effects of CPAP on TPN 
and DMN networks of untreated OSA patients as compared to sham CPAP treatment and 
HC. 
Our results show that active- and sham-CPAP groups follow opposite trends of cerebral 
activation after 2 months of treatment. Whereas sham-CPAP group exhibited a decrease in 
TPN activation associated to an increase of DMN deactivation at the limit of capacity task 
(3-back), the active CPAP group presented an increase of TPN activation et all task levels, 
associated with an increase of DMN deactivation in the anterior midline at 3-back. In 
association with a significant improvement of response times (at 2 and 3-back) and accuracy 
(2-back) in the active group, these findings suggest a positive effect of CPAP on the active-
treatment group when the sham-CPAP group seems to sustain additional effects of untreated 
OSA.  
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An alternative interpretation of our results for the sham group is that sham-CPAP per se had 
a negative impact as it may lead to more mouth-breathing and sleep disruption. Significant 
worsening of RTs and decreased TPN activation at the 3-back after 2 months of sub-
therapeutic treatment in the sham group reflect a rather faster evolution than what would be 
expected of untreated OSA-related effects. Increased deactivation of the DMN has been 
previously reported by Sweet at al after two nights of CPAP withdrawal and correlated with 
better behavioral performance and higher sleepiness68. Thus our finding of increased spatial 
recruitment of DMN in the sham CPAP group for the 3-back task is consistent with these 
previous results and with our hypothesis of increased sleep disruption secondary to sham 
CPAP use.  
Basal ganglia (BG) have been previously reported to show specifically load-dependent 
activation69 and be activated during complex WM tasks (2-back)70, 71. Drummond et al have 
described higher activation in bilateral putamen and caudate for fast as compared to slow 
RTs after a normal sleep night using a Psychomotor Vigilance Task55. After acute sleep 
deprivation (SD) there was an increase in activation in those regions for slow, but not fast 
RTs. Similarly, Habeck et al found increased activation in BG after acute SD, which may 
reflect an increased effort in order to maintain adequate level of attention and arousal72. Our 
sham group patients exhibited significantly higher BG activation on pre-treatment as 
compared to post-treatment session, which, in association with slower RTs at 3-back may 
reflect lower capacity for WM performance. 
Defective deactivation of DMN regions has been reported to be related to worse behavioral 
performance in a number of conditions associated with cognitive impairment and sleep 
disturbances (normal aging, Parkinson disease, schizophrenia, ADHD), suggesting that 
inability to reallocate neuronal resources and suppress activity in neighboring regions plays a 
role in cognitive impairment.50-53 Disruption of task-related deactivation within the midline 
regions of DMN has been reported after acute sleep deprivation,54 and slower reaction times 
on a psychomotor vigilance task have also been associated with increased activation in 
midline DMN regions after total sleep deprivation,55 suggesting that sleep deprivation has a 
direct impact on DMN. Similarly, reduced deactivation in the posterior regions of DMN has 
been shown to be related to attentional lapses in healthy subjects56. Furthermore, Mitzenberg 
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et al have demonstrated that task-induced deactivation in the ventro-medial PFC significantly 
predicted speeding of RTs on a sensori-motor task after administration of Modafinil73. 
Modafinil inhibits norepinephrine and dopamine transporters, leading to increased synaptic 
NE and DA concentration and has been shown to enhance cognitive performance in both 
OSA patients and healthy individuals74.Therefore the observed increase of deactivation in 
vmPFC together with speeding of RTs in our active-treatment group could indicate an 
improvement in catecholamine systems modulation of the DMN, reflecting an improved 
arousal level. 
Despite randomization, our patient groups differed in BMI, with active-CPAP group being 
more overweight. This was associated with a significant negative correlation between BMI 
and the behavioral performance at the 3-back level in OSA patients, as well as OSA group 
differences in the behavioral performance at the intermediate (2-back) and maximal WM 
loads (3-back), with active-treatment group performing significantly worse than HC, 
although there was no significant difference between the active and sham-CPAP groups. In a 
previous report we showed that BMI had a major negative impact on the cerebral activation 
in the TPN, particularly in the prefrontal regions75. Although there was a trend towards better 
performance on the 3-back task load after CPAP treatment in the active group, it still 
remained significantly worse than that of HC. The incomplete reversal of deficits by CPAP 
treatment has been attributed in prior literature to irreversible structural hypoxic damage, 
however, since we found an independent negative effect of BMI on TPN activation in the 
PFC, we postulate that the incomplete response to CPAP treatment may also be related to the 
presence of overweight, unchanged by CPAP treatment alone. This is supported by the fact 
that nasal CPAP does not act on the restrictive aspect of thoracic breathing presented by 
obese OSA patients, who thus will persist having breathing problems during sleep even if 
they translate only by airflow limitation and lower oxygen saturation than expected for their 
age group. Furthermore, other mechanisms than impaired breathing, such as metabolic and 
hormonal changes associated with obesity, likely contribute to the observed cerebral 
activation deficit. 
It is increasingly recognized that excess body weight is associated with brain structural and 
functional alterations63, a higher risk of developing dementia in later life40, as well as 
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cognitive dysfunction in otherwise healthy adults or after controlling for BP, age, and 
diabetes40, 41, 66. Therefore, it would be of great interest to examine whether reduction in BMI 
in conjunction with CPAP treatment could improve executive function deficits in OSA 
patients. 
OSA patients in our study were all high-performing individuals which suggests that neuronal 
damage secondary to OSA was rather minimal. The role of CPAP treatment in those 
individuals might therefore reside not so much in improving performance, but in protection 
from further damage. In that sense, longitudinal studies of CPAP effects on initially well 
performing patients would be needed in order to assess the degree of protection that CPAP 
treatment might offer and tease apart the contribution of CPAP versus placebo effect in the 
long term.  
Two other studies have investigated the effect of CPAP on cerebral activation of OSA 
patients. Thomas et al have found no improvement in DLPFC activation on a verbal 2-back 
WM task in 6 OSA patients after CPAP treatment, although there was some increase in the 
parietal activation29. Since their patient group had performed significantly worse than HC at 
baseline and did not improve after treatment, the lack of cerebral activation changes in the 
DLPFC was interpreted as an indication of a more permanent cerebral damage. No 
information was reported on the deactivation pattern. 
More recently Castronovo et al examined the effect of CPAP on cerebral activation on a 
verbal 1- and 2-back WM task in 17 OSA patients32. Greater spatial activation was reported 
in a number of prefrontal regions, bilateral precuneus, left putamen, left hippocampus and 
was interpreted as a compensatory over-recruitment. Whereas more extensive activation in 
the PFC of never treated OSA patients in the presence of the same level of performance is 
indeed suggestive of over-recruitment of the TPN, more important activation in the 
hippocampus and precuneus were more difficult to explain. However, these latter 
observations are consistent with our hypothesis and findings of defective DMN functioning 
in OSA, as both hippocampus and precuneus are constituents of DMN. Furthermore, the 
authors have found an increased activation in bilateral hippocampus, fusiform gyrus and 
ACC (BA 24) in the preatreatment as compared to posttreatment scans in OSA patients, 
42	  
	  
which is consistent with less effective DMN at baseline with subsequent improvement after 
treatment. 
Those findings as well as results of our study are in line with our previous observation that 
DMN is more severely affected by OSA than TPN75. 
In light of the results of functional and structural neuroimaging studies it appears that CPAP 
treatment could be most useful in high-functioning OSA patients, by preventing or at least 
slowing OSA-related neuronal damage. Further long-term longitudinal studies are needed in 
order to investigate this hypothesis. Finally, high-functioning OSA patients should be tested 
with limit-of-capacity tasks in order to avoid ceiling effects. 
 
In conclusion, both TPN and DMN can show spatial over-recruitment in OSA patients in 
order to maintain an adequate behavioral response. When the compensation capacity is 
overwhelmed, decrease in behavioral performance is observed. In our study we found that 
OSA patients’ performance accuracy significantly differed from that of HC only at the limit-
of-capacity 3-back WM level. However, RT of accurate responses was a more sensitive 
measure of impairment, showing a significant patient group versus treatment interaction. 
CPAP treatment appears to have a generally positive effect on both cerebral activation and 
deactivation patterns, however, in accord with previous studies, it does not allow complete 
reversal of already established deficits, at least within two months of CPAP treatment.  
Increased BMI has an independent negative effect on TPN activation in the PFC and may 
thus account for part of the remaining deficits.  
Further research is needed in order to establish whether a conjunct treatment of obesity and 
CPAP could yield better improvement in behavioral performance and frontal TPN activation 
than CPAP treatment alone.  
  
 
 
 
43	  
	  
Table 5: Sample characteristics 
 
    
Age 43.2 (±8.4) 
BMI 27.8 (±4) 
AHI 39.7 (±22.8) 
Ethnicity 
4 Asian, 12 Caucasian, 1 
Hispanic 
TST 376.8 (±71.1) 
Sleep 
efficiency 83.1 (±13.1) 
REM 17.9 (±4.9) 
Stage 1 12 (±7.3) 
Stage 3+4 7.9 (±8.9) 
Min SpO2 87.8 (±8.9) 
    
 
BMI = body mass index, AHI = apnea hypopnea index, TST = total sleep time 
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Table 6: Behavioral performance 
 
                
 Sham-CPAP group Actif-CPAP group HC 
Sham vs 
HC Actif vs HC 
 pre-treatment post-treatment pre-treatment post-treatment p value  p value 
        
Accuracy 0-back 98.8 (+/-3.5) 98.8 (+/-2.3) 99.3 (+/-1.2) 99 (+/-2.4) 99.5 (+/-0.8) 0.6; 0.5 0.6; 0.6 
RT 0-back 436.9 (+/-52.7) 440.4 (+/-79.4) 493.6 (+/-165.6) 501.5 (+/-159.8) 446.2 (+/-117.5) 0.9; 0.9 0.5; 0.4 
Accuracy 1-back 98 (+/-2.4) 98.3 (+/-3.1) 95.5 (+/-6) 97.3 (+/-2.2) 96.3 (+/-4.3) 0.4; 0.4 0.8; 0.6 
RT 1-back 719.4 (+/-168.5) 867 (+/-249.8) 801.2 (+/-165.5) 703.3 (+/-323) 671.3 (+/-182.8) 0.6; 0.1 0.2; 0.8 
Accuracy 2-back 93.2 (+/-0.3) 91.1 (+/-7.3) 89.7 (+/-7.9) 89.3 (+/-7.2) 93.6 (+/-5.3) 0.9; 0.5 0.3; 0.2 
RT 2-back 838.5 (+/-361.3) 1184.9 (+/-443.2) 1114.4 (+/-219) 909.7 (+/-278.7) 806.8 (+/-274.2) 0.9; 0.7 0.03;  0.5 
Accuracy 3-back 83.1 (+/-11) 86.2 (+/-6.6) 75.2 (+/-9.2) 78.7 (+/-11.6) 89 (+/-5.2) 0.2; 0.4 0.002; 0.04 
RT 3-back 1014.5 (+/-337.5) 1349.9 (+/-220.3) 1359.5 (+/-211.5) 1083.2 (+/-357.7) 992.1 (+/-239.6) 0.9; 0.01 0.008; 0.6 
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Table 7: Cerebral regions showing significant activation and deactivation after exclusive 
masking in sham CPAP group (MNI coordinates). 
Region X Y Z Brodman  Region X Y Z Brodman  
Exclusive masking baseline by post-treatment 
scan          
      
 1>0    0>1  
 none    none  
 2>0    0>2  
R middle/inf frontal   34  56 -14 10 L middle frontal/ant cingulate -26  38 -16 
 
11/10/32 
R inf/middle frontal  58  20  22 9 R medial frontal    6 -12  62 6 
L inf frontal  -34  32  -4 47 L sup frontal  -22  40  48 8 
R inf/middle frontal  40  36  -8  47/10 L cuneus  -4 -92  32 19 
R precentral   42  -2  30 6 L sup/middle temporal  -42  16 -34  38/21 
R middle frontal   30  40  22 9 L insula/sup temporal -40 -24  20  13/41 
R sup frontal  36  30  48 8 R ant cingulate   4  22 -10 25/24 
L middle frontal  -32  26  22 9 R insula  52 -24  16  41/13 
L inf parietal lobule  54 -28  40 40 L insula -36   4  12 13 
L precuneus  30 -72  22 31 L cingulate   -8 -34  38 31 
L lingual  -18 -82 -2  18/19 L post cingulate  -6 -68  18  31/30 
R lingual   26 -74  -4 19 R ant cingulate  16  32 -16 32 
L fusiform  -44 -48 -10 37     
R fusiform   52 -36 -14 37     
R middle temporal   64 -40   4 22/21 R ant cingulate  10  40 -12 24 
R middle temporal   64 -54  -8 37 Culmen -12 -36 -10  
L uvula -10 -74 -30    0>3  
R hippocampus  40 -32  -8  R medial frontal   10  -6  66 6 
L thalamus  -6 -20  18  L sup/medial frontal -10  66   8 10 
R thalamus   8 -14  20  L sup/medial frontal  -24  30  48 8 
L lentiform nucleus -12   0   2  L middle frontal  -22  28  56 6 
 3>0  R precentral   66  -8  38 6 
R middle frontal  40  18  52 6 L middle frontal  -46  36   8 46 
R precentral  44  26  38 9 L precentral  -28 -20  70  4/6 
R sup/middle frontal   42  44  26 9 L sup frontal  -12  56 -12 10 
R sup/middle frontal   36  58   6 10 R middle frontal   56  38   6 46 
L middle frontal  -44  32  38 8 R precentral   44 -10  60 4 
R middle frontal   52  18  38  8/9 L sup/middle frontal  -20  42  28  9/8 
L middle frontal  -52  18  36 8 R postcentral   26 -20  64 3 
R insula  32  30   0 13 R postcentral   28 -38  74 5 
R cingulate  10  28  38 32 L postcentral  -22 -26  64 3 
R sup parietal lobule  28 -60  60 7 R precuneus/cuneus  10 -74  34  31/19 
R inf temporal   64 -38 -16 20 L inf parietal lobule -32 -46  64 40 
L claustrum -30  26  -4  L paracentral lobule -22 -38  50 5 
   L precuneus  -4 -60  34 31 
   R inf parietal lobule  66 -32  32 40 
   L sup occipital  -42 -78  36 19 
   R parahippocampal/amygdala   24  -6 -22  
   R sup temporal   52   8 -20 38 
   
L 
hippocampus/parahippocampal -24 -36 -2  
   R fusiform/parahippocampal  38 -48 -10 
 
37/19/36 
   L sup temporal  -44 -46  18 13 
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   R cingulate   24 -26  36 31 
   R ant cingulate   6  20 -16 25 
   R ant cingulate   0  22  18 24 
   L cingulate  -20 -26  46 31 
   L insula -38   4  18 13 
   L thalamus  -4  -2   4  
   R thalamus   6   0  10  
   R med globus pallidus  20  -6  -4  
   L putamen -16  18 -14  
      
Region X Y Z Brodman  Region X Y Z Brodman  
Exclusive masking post-treatment scan by 
baseline           
 1>0    0>1  
R cuneus   6 -80  44 19   none  
 2>0    0>2  
L sup/medial frontal  -10  -8  70 6   none  
L middle frontal  -38  36  34  9/8   0>3  
L precentral  -58   6  36 6 L middle frontal  -34  22  48 6 
L middle frontal/precentral  -30   6  40 6 R sup frontal   14  68  20  9/10 
L precentral  -38 -10  62 4 L inf frontal  -58  20  12 44 
R sup frontal   28  54 -14 10 L sup frontal  -20  54  18 10 
R inf frontal   30  34  -8 47 L paracentral lobule  -4 -30  62 5 
R medial frontal   24  56   0 10 R paracentral lobule   0 -36  66 5 
R middle frontal   38  42  36 8 L postcentral  -34 -16  50  3/2 
R inf frontal  -34  38  12 46 
L sup parietal 
lobule/precuneus -14 -54  74 7 
L precentral  -44  24  34 9 R precuneus  28 -40  50 7 
R medial frontal   26  46  10 9 R cuneus  16 -86  40 19 
L sup frontal   -6  26  48 8 L cuneus -16 -78  14 17 
L precuneus/cingulate  -4 -68  58  7/31 L sup temporal  -48 -20 -8  22/21 
R precuneus/cuneus  14 -62  34  31/7 R sup temporal   52 -16 -14 22 
L inf parietal lobule -40 -50  64 40 L fusiform/middle tmporal -38 -10 -28  20/21 
R inf parietal lobule  56 -42  26 40 R ant cingulate  12  14  20 33 
L angular  -54 -62  42 39 R cingulate   12   4  34 24 
R angular  60 -58  38 39 R ant cingulate   6  44   0 32 
L precuneus -30 -78  46 19 L cingulate   -2  26  32 32 
R lingual   14 -88   0 18 R post cingulate   4 -24  22 23 
L lingual   -8 -82  -6  18/17 L insula -54 -34  26 13 
R inf temporal/parahippocampal  58 -28 -20  20/36 R insula  46 -24  -4 13 
L sup temporal  -50  10 -22 38 L caudate head  -8  16 -14  
L sup temporal  -54 -50  10 22 L caudate body  -2  12   4  
L middle temporal  -30 -62  28 39 R caudate body   8  24   8  
L sup temporal  -50 -48  10 39 R caudate head  16  24 -16  
R middle temporal   44 -82  28 19 L caudate tail -12 -30  24  
L inf temporal  -5 -34 -12 20 R thalamus   0 -20   2  
L fusiform  -46 -60 -8 37 L pyramis -20 -88 -26  
R cingulate  22 -42  38 31 R culmen  10 -38 -10  
R cingulate   14  28  30 32 L declive -12 -70 -14  
L post cingulate  -8 -34  24 23 L culmen  -2 -72  -8  
L ant cingulate -22  54   0 32     
L insula/putamen -38  16   8 13     
R insula  36  18  10 13     
L insula -34  32   6 13     
R lentiform nucleus  12  -2  -2      
L lentiform nucleus -16 -2 -2      
 3>0      
L inf frontal -46   2  24 9     
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Table 8: Cerebral regions showing significant activation and deactivation after exclusive 
masking in the active CPAP group (MNI coordinates). 
 
Region X Y Z Brodman  Region X Y Z Brodman  
Exclusive masking baseline by post-treatment scan    
 1>0    0>1  
 none  R sup frontal    2  52  44 8 
 2>0  L sup frontal  -16  42  50  8/6 
L middle frontal  -44  18  38 9 R/L medial frontal   0 -12  68 6 
L middle frontal  -32  10  40 6 L precentral  -44 -14  36  4/6 
 3>0  R middle frontal   28  42 -18 11 
L middle frontal  -38  24  22 9 R middle/inf frontal   40  40 -16 47 
L sup frontal -36  58   6 10 R precentral   38 -16  58 4 
R middle frontal   34   8  46 6 R medial frontal    8  54  -8 10 
R middle frontal   38  24  28 9 L medial frontal  -18  52  -6 10 
L inf parietal lobule -52 -38  56 40 L superior/medial frontal   -8  68  16 10 
R inf temporal  56 -50 -12 37 R medial frontal    4  62   0 10 
   L medial frontal   -2  66   6 10 
   R medial frontal  10  30 -22 11 
   L inf parietal lobule -48 -26  30 40 
   L postcentral  -56 -14  50 1 
   L postcentral  -46 -14  60 3 
   L postcentral  -42 -30  60 40 
   L postcentral  -52 -24  58 2 
   L postcentral  -38 -42  64 5 
   Postcentral Gyrus  30 -26  64 3 
   R sup parietal lobule/precuneus  28 -50  72 7 
   R postcentral   44 -30  62 40 
   R postcentral   52 -24  56 2 
   R postcentral   40 -40  64 5 
   L precuneus -24 -80  50 19 
   L inf occipital  -42 -78   0 19 
   L lingual  -22 -84 -2 18 
   R lingual   34 -64   8 19 
   L cuneus  -6 -80  18 17 
   L middle occipital -40 -88  16 19 
   L middle temporal  -64 -42   0 21 
   L inf temporal  -52 -76   4 19 
   R fusiform/parahippocampal  44 -10 -32  20/36 
   R sup temporal   58   2 -16 38 
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   L middle temporal  -46 -68  30 39 
   L cingulate   -8   0  44 24 
   R post cingulate  32 -74  12 30 
   R ant cingulate  22  44   2 32 
   L ant cingulate -22  48 -12 10 
   R cingulate   20 -30  42 31 
   R cingulate   16 -12  42 24 
   R post cingulate  18 -58  20 30 
   R ant cingulate   4  26 -18 32 
   L caudate  -8 -14  26  
   L putamen -20  16   6  
     0>2  
   L inf/middle frontal -32  28 -16 47/11 
   L middle frontal  -34  40 -18 47 
   R precentral  64 -12  38  4/6 
   L sup frontal  -20  42  52 6 
   R middle/sup frontal   22  44  36 8 
   L medial frontal  -12  62   2 10 
   R medial frontal    6  54 -14 10 
   L medial frontal   -4 -12  56 6 
   R sup frontal   16  56  28  8/9 
   R inf frontal   44  34   2 13 
   L postcentral  -14 -44  76 7 
   L inf parietal lobule -58 -32  26 40 
   R sup parietal lobule/postcental  30 -38  66 5 
   R inf parietal lobule  54 -26  28 40 
   R postcentral   64 -14  22 3 
   R postcentral   52 -18  56  3/2 
   L postcentral  -44 -14  54 3 
   R cuneus   8 -72  20 18 
   R cuneus  14 -94  34 18 
   R middle occipital   40 -78   8 19 
   L lingual  -36 -72   0 18 
   R lingual   16 -52   4 19 
   R sup temporal   54   2  -6 22 
   R parahippocampal   28 -46 -12 36 
   R fusiform   46 -16 -32 20 
   L middle temporal  -58 -2 -6 21 
   L sup temporal  -58   8 -12 38 
   R inf temporal   50 -66  -4 37 
   R sup temporal   66 -28   6 22 
   L sup temporal  -50  10 -32 28 
   R parahippocampal   22 -14 -26  
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   R middle temporal   54   0 -34 21 
   L sup/middle temporal  -54  12 -20 38/21 
   L cingulate   -4   2  34 24 
   R cingulate    6   6  42 24 
   R ant cingulate   4  24  10 33 
   R post cingulate   4 -64  12 30/23 
   L cingulate   -6   0  44 6 
   L cingulate -12 -22  40 31 
   L insula -44 -26  24 13 
   L claustrum -30   4  10  
   R claustrum  42   8  -6  
     0>3  
   R inf frontal  40  32 -16 47/13 
   L paracentral lobule/postcentral -18 -30  60 3,7 
   L inf/middle frontal  -38  28 -16 47 
   L medial frontal -10  60  -6 10 
   R precentral   24 -16  70 4 
   R medial/sup frontal   0  50  32 
Brodmann area 
6/9 
   L sup frontal  -16  48  44 8 
   R medial frontal    0 -18  74 6 
   L medial frontal   -6 -12  58 6 
   L inf frontal  -32  16 -30 47 
   L paracentral lobule  -4 -42  68 
Brodmann area 
5/6 
   R medial/sup frontal  12  66  -4 10 
   R precentral   40  -8  38 6 
   R inf parietal lobule  52 -28  30 40 
   L precuneus -14 -60  34 31 
   L inf parietal lobule -54 -28  26 40 
   L cuneus -14 -74  28 18/19 
   R middle occipital/temporal  54 -74   6 37/39 
   R lingual    0 -92  10 17/18 
   R middle occipital  -32 -90   4 18 
   R fusiform/hippocampus  38 -46 -16 37 
   R sup temporal/insula  52   0  -6 22/13/38 
   Uncus  32  -8 -30  
   L parahippocampal  -30 -34 -22 36 
   L sup temporal  -50   4 -30 38 
   L middle temporal  -48 -64  12 37 
   L claustrum, insula/putamen -38 -16 -4  
   L post cingulate -16 -66  14 30 
   R cingulate   16   4  42 24 
   R ant cingulate   0  10 -16 25 
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   L cingulate   -6 -12  36 23/24/31 
   R ant cingulate   4  50 -14 32 
   R post cingulate   8 -40  12 29 
   R putamen  32  -4   4  
   R putamen/claustrum  40 -22   2  
      R pulvinar  18 -22   8   
Exclusive masking post-treatment scan by baseline     
  1>0    0>1  
L precentral -32  -2  62 6 L precentral  -62  -6  12 43 
R middle frontal   34   0  58 6 R inf frontal  50  40   4 46 
R middle/sup frontal  50  30  26  9/10 R medial frontal   10  54  12 9 
R sup frontal    4  28  48 8 L inf parietal lobule -64 -26  34 40 
R medial frontal   16   8  60 6 L middle occipital  -38 -66   2 37 
R middle frontal   46   8  52 6 R cuneus   6 -76  24 18 
L middle frontal  -42  54  12 46 L middle temporal  -48 -68  10 37 
R inf frontal   52  10  30 9 L middle/sup temporal  -56 -38   6 22 
R inf frontal   54  16  16 44 R middle temporal/occipital  50 -66  12 37/19 
R middle frontal   36   0  46 6 L ant cingulate  -2  30  14 24 
R precentral   38   0  36 6 R insula  48   2   2 13 
R inf parietal lobule  48 -48  44 40 L subcallosal  -10   0 -16 34 
L inf parietal lobule/supramarginal -50 -48  42 40 L medial globus pallidus -14 -6 -8  
L middle temporal  -58 -30 -14 21   0>2  
R insula  42  24   2 13 L sup/medial frontal  -20  26  48 8 
  2>0  R sup frontal   10  42  44 8 
L precentral  -28  -4  66 6 L sup frontal  -18  60  16 10 
R precentral   38  -2  62 6 L sup frontal  -26  30  48 8 
L inf/middle frontal  -58  12  32  9/8 R precuneus/lingual   6 -64  32 31/18 
L precentral  -44   2  32 6 L postcentral  -50 -18  52 2 
R middle/sup frontal   36  44  32  9/10 R cuneus  16 -80  26 18 
L sup/middle frontal  -40  48  28 9 R inf/middle occipital   22 -96  -8 17/18 
L sup parietal lobule -18 -64  62 7 R parahippocampal   28 -22 -12 28 
R inf parietal lobule  46 -32  34 40 L middle/sup temporal  -54 -36  10 22/41 
R sup parietal lobule  12 -60  66 7 L sup temporal  -58 -16   2 22 
R precuneus  26 -70  62 7 L middle temporal  -52 -68  26 39 
L precuneus -20 -70  32 31/7 R sup temporal   64  -4  -2 22 
R precuneus  26 -70  38 19 R sup temporal  54 -24   4 41 
L inf parietal lobule -52 -30  36 40 L parahippocampal -20 -20 -12 35 
L supramarginal/sup parietal lobule -52 -42  38 40 R ant cingulate  10  44   6 32 
R supramarginal   56 -46  36 40 R subcallosal   14   0 -18 34 
R lingual/cuneus  22 -74   0 18/17 L post cingulate -12 -68  20 31 
L middle occipital  -28 -82  26 19 L cingulate/precuneus  -6 -54  36 31 
L lingual  -30 -64 -2 19 R ant cingulate   6  32   2 24 
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R cuneus  30 -78  24 18 R insula/claustrum  42 -14  14 13 
R parahippocampal/lingual  40 -54   2 19 L ant cingulate -16  44   6 32 
L fusiform  -48 -54 -8 37 L insula -42 -10   8 12 
R insula  38  22   6 13   0>3  
L insula -34  18   8 13 R precentral   52 -10  24 6 
R cingulate    6  24  40 32 L postcentral/precentral -22 -22  70 3,4 
  3>0  R precentral/postcentral  44 -18  58 4,2 
L precentral -28  -4  68  6/4 L medial frontal/cingulate -10 -18  50 6,24 
R precentral   36  -4  64 6 L sup frontal -18  60  14 10 
R middle frontal   32  34  40 8 L sup frontal  -12  32  48 6,8 
L sup frontal  -10   2  70 6 R precentral   68  -6  26 4 
R sup/middle frontal   32  52  14 10 L inf frontal  -30  28 -18 47 
L sup frontal  -32  44  28 9 L postcentral   -8 -38  74 5,7 
L middle frontal  -36  46  10 10 L precuneus -12 -36  54 7 
L supramarginal/inf parietal lobule -54 -40  38 40 L inf parietal lobule -44 -26  52 40 
R inf parietal lobule  58 -38  42 40 R postcentral   28 -26  48 3 
L precuneus -18 -62  38 7 L inf parietal lobule -32 -34  64 40 
R cuneus  24 -72  38 7 R lingual   22 -92   0 17 
L middle occipital  -28 -84  28 19 R middle occipital/cuneus  14 -92  20 18/17 
culmen   6 -44 -26  R middle occipital   54 -72  -6 37 
    L lingual  -14 -54   0 19 
    L inf occipital/cuneus -20 -98 -4 17 
    L fusiform  -42 -76 -8 19 
    L transverse temporal/insula -34 -38  14 41/13 
    L sup temporal  -56 -40  12 22 
    R parahippocampal/amygdala  28 -22 -12 28 
    R sup temporal   56 -18  -4 22 
    L middle temporal  -36 -60  20 19 
    R parahippocampal/post cingulate  18 -42  -6 30/29 
    R fusiform   32 -82 -10 19 
    L parahippocampal  -26 -26 -14 28/27 
    R sup temporal   46   8 -36 38 
    L sup temporal  -44   8 -36 38 
    R inf temporal   46 -10 -34 20 
    L sup temporal  -54 -14 -14 22 
    R ant cingulate/caudate  14  34   0 24 
    R cingulate   20 -24  48 31 
    L cingulate  -18  32  22 32 
    R post cingulate   0 -58   8 30 
    L cingulate/caudate tail -16 -42  32 31 
    R insula  32 -30  20 13 
    L insula -46  -6  20 13 
    L subcallosal   -8   0 -16 34 
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    R putamen/lat globus pallidus  24   8 -14  
    R caudate  24   2  28  
        2   2  -2  
    L caudate  -4   8   4  
      Thalamus   0  -6   0   
 
 
 
 
Table 9: Cerebral regions showing significant activation/deactivation differences on a paired 
t-test between pre- and post-treatment sessions for active and sham groups. 
 
region X  Y  Z  
Brodman 
area 
 
Sham-CPAP 
group      
R middle frontal  56 24 34  9/8 
R sup frontal g 22 54 24 9 
L inf frontal  -34 22 -22 47/putamen 
R precentral g 52 10 36 4-Jun 
L sup/middle temporal  -50 -32 -2  21/22 
L middle occipital  -22 -84 24 18/19 
L sup temporal  -42 4 -18 38 
R putamen/caudate head 24 22 -6  
 24 6 -10  
L globus pallidus -12 6 -12  
L caudate body -16 14 12  
     
 
Active-CPAP 
group      
L sup temporal  -66 -36 22 22 
L middle occipital  -12 -94 18 18 
 -26 -98 20 18 
R cuneus 20 -86 14 7 
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Figure 4: Cerebral activation (warm scheme) and deactivation (cold scheme) exclusive 
masking of pre-treatment session by post-treatment session (A); and of post-treatment 
session by pre-treatment session (B) in the sham-CPAP group for 2 vs 0-back and 3 vs 0-
back contrasts (FDR multiple comparisons correction, p=0.05, 10voxels).  
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Fig.5: Cerebral activation (warm scheme) and deactivation (cold scheme) exclusive masking 
of pre-treatment session by post-treatment session (A); and of post-treatment session by pre-
treatment session (B) in the actif-CPAP group for 1 vs 0-back, 2 vs 0-back and 3 vs 0-back 
contrasts (FDR multiple comparisons correction, p=0.05, 10voxels). 
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Figure 6: brain regions showing significantly higher brain activation in pre-treatment as 
compared to post-treatment session in sham-CPAP (A) and actif-CPAP (B) groups on a 
paired t-test. 
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Conclusions 
The goal of our work was to investigate the patterns of cerebral activation and 
deactivation in the TPN and DMN during the performance of a parametric WM task and 
to compare them to those of HC, as well as to assess the effect of CPAP treatment as 
compared to sham-CPAP. 
In our study we found that OSA patients’ performance accuracy significantly differed 
from that of HC only at the limit-of-capacity 3-back WM level. However, RT of accurate 
responses was a more sensitive measure of impairment, showing a significant patient 
group vs treatment interaction. 
Our results revealed impairment of both TPN and DMN in our OSA patients, although to 
a different extent and by different factors. Whereas nocturnal desaturation has a negative 
impact on both TPN and DMN by decreasing cerebral activation in the former and 
increasing it in the latter, its major impact appears to be on the DMN dysfunction. BMI 
per se has a negative effect, predominantly on prefrontal regions, decreasing cerebral 
activation in the TPN and showing a significant negative correlation with behavioral 
performance at the maximal level of WM load. Cerebral activation in the TPN network is 
thus negatively affected by both nocturnal desaturation and the BMI, whereas DMN 
deactivation is mostly impaired by nocturnal desaturation.  
Thus, it appears that both TPN and DMN can show spatial over-recruitment in OSA 
patients in order to maintain an adequate behavioral response. When the compensation 
capacity is overwhelmed, decrease in behavioral performance is observed. CPAP 
treatment appears to have a generally positive effect on cerebral activation and 
deactivation pattern in OSA patients, however, it appears that its main effect is that of 
preventing or at least slowing the development of OSA-related damage, more than 
reversing the already established deficits.  Increased BMI has an independent negative 
effect on TPN activation in the PFC which is not sufficiently improved by CPAP 
treatment alone.  
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Further research is needed in order to establish whether a conjunct treatment of obesity and 
CPAP could yield better improvement in behavioral performance and frontal TPN activation 
than CPAP treatment alone.  
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